Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,669 | 579 | 99.6% |
| Education | $46.53 | 7 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,897 | 98 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,071 | 52 | $0 (2024) |
| Lilly USA, LLC | $1,055 | 59 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $985.27 | 39 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $742.61 | 43 | $0 (2023) |
| Novo Nordisk Inc | $730.50 | 41 | $0 (2024) |
| PFIZER INC. | $663.99 | 34 | $0 (2024) |
| ABBVIE INC. | $626.67 | 25 | $0 (2024) |
| Merck Sharp & Dohme LLC | $600.91 | 41 | $0 (2024) |
| Amgen Inc. | $568.71 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,371 | 98 | Boehringer Ingelheim Pharmaceuticals, Inc. ($313.79) |
| 2023 | $2,637 | 103 | AstraZeneca Pharmaceuticals LP ($371.67) |
| 2022 | $668.03 | 28 | AstraZeneca Pharmaceuticals LP ($199.44) |
| 2021 | $20.40 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($20.40) |
| 2020 | $277.46 | 15 | Lilly USA, LLC ($49.61) |
| 2019 | $1,865 | 113 | AstraZeneca Pharmaceuticals LP ($299.59) |
| 2018 | $1,825 | 111 | AstraZeneca Pharmaceuticals LP ($321.01) |
| 2017 | $2,051 | 117 | Janssen Pharmaceuticals, Inc ($425.58) |
All Payment Transactions
586 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: Obesity | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Diabetes | ||||||
| 12/07/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: AMANTADINE | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: DIABETES | ||||||
| 11/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Inflammation | ||||||
| 11/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: NEUROLOGY | ||||||
| 11/12/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: Neuroscience | ||||||
| 11/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $32.20 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: DIABETES | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: RESPIRATORY | ||||||
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Obesity | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: RESPIRATORY | ||||||
| 09/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.84 | General |
| 09/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $32.98 | General |
| Category: Oncology | ||||||
| 09/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: Diabetes Care | ||||||
| 08/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.97 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 375 | 726 | $90,836 | $25,216 |
| 2022 | 12 | 464 | 894 | $121,608 | $36,850 |
| 2021 | 8 | 301 | 686 | $67,932 | $22,556 |
| 2020 | 7 | 310 | 572 | $49,367 | $17,066 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 102 | 291 | $59,073 | $13,901 | 23.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 15 | 15 | $9,570 | $4,219 | 44.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 109 | 269 | $1,614 | $1,576 | 97.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 26 | $7,488 | $1,501 | 20.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 39 | 39 | $1,989 | $1,334 | 67.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 16 | 16 | $2,704 | $1,151 | 42.6% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 23 | 23 | $1,192 | $502.08 | 42.1% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 21 | 21 | $5,460 | $467.80 | 8.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $612.00 | $410.40 | 67.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 14 | $1,134 | $154.03 | 13.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 112 | 327 | $66,381 | $15,569 | 23.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 53 | 53 | $33,814 | $14,796 | 43.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 45 | 48 | $2,448 | $1,621 | 66.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 28 | 29 | $1,479 | $986.31 | 66.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 13 | 13 | $2,041 | $891.02 | 43.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 109 | 283 | $1,698 | $830.56 | 48.9% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 33 | 36 | $1,760 | $757.00 | 43.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 11 | 11 | $4,235 | $729.29 | 17.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 17 | 20 | $1,620 | $245.21 | 15.1% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2022 | 13 | 28 | $868.00 | $161.92 | 18.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 19 | 19 | $4,940 | $147.58 | 3.0% |
| 85610 | Blood test, clotting time | Office | 2022 | 11 | 27 | $324.00 | $115.02 | 35.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 93 | 287 | $55,715 | $18,117 | 32.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 13 | $3,509 | $928.32 | 26.5% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 13 | 14 | $1,708 | $909.36 | 53.2% |
About Dr. Anthony Wong, MD
Dr. Anthony Wong, MD is a Internal Medicine healthcare provider based in Irvine, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1104808443.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Wong, MD has received a total of $11,716 in payments from pharmaceutical and medical device companies, with $2,371 received in 2024. These payments were reported across 586 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($11,669).
As a Medicare-enrolled provider, Wong has provided services to 1,450 Medicare beneficiaries, totaling 2,878 services with total Medicare billing of $101,688. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Irvine, CA
- Active Since 11/14/2005
- Last Updated 10/13/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1104808443
Products in Payments
- FARXIGA (Drug) $1,525
- JARDIANCE (Drug) $649.19
- TRULICITY (Drug) $546.15
- XARELTO (Drug) $498.97
- TRELEGY ELLIPTA (Drug) $448.43
- Enbrel (Biological) $408.20
- JANUVIA (Drug) $317.15
- UBRELVY (Drug) $305.36
- ELIQUIS (Drug) $249.37
- INVOKANA (Drug) $243.64
- QULIPTA (Drug) $230.37
- TOUJEO (Drug) $217.61
- AIRSUPRA (Drug) $211.03
- Tresiba (Drug) $185.91
- Cologuard Collection Kit (Device) $183.58
- BREO (Drug) $175.77
- Wegovy (Drug) $175.23
- OFEV (Drug) $173.32
- Ozempic (Drug) $160.19
- EMGALITY (Drug) $153.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Irvine
Dr. Tung Ngo, Do, DO
Internal Medicine — Payments: $4.9M
Rashmi Kumar, Md, MD
Internal Medicine — Payments: $121,958
Dr. Irene Kang, M.d, M.D
Internal Medicine — Payments: $55,000
Dr. Behdad Akbarpour, Md, MD
Internal Medicine — Payments: $34,097
Dr. Maher Kassis, M.d, M.D
Internal Medicine — Payments: $30,310
Dr. Shanta Chawla, Md, MD
Internal Medicine — Payments: $17,484